Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-11

Clinical Trial Update: Evaluation of DIAMEL® Combined With Insulin in Diabetic Foot Ulcer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating DIAMEL combined with insulin for diabetic foot ulcers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diamel
  • Insulin (insulin)

Snippet

Sponsor: Catalysis SL | Conditions: Diabetic Foot Ulcer, Diabetic Foot | Phase 2 | Status: COMPLETED